Bluefin Biomedicine

First-in-class antibody medicines grounded in human biology

Beverly, United States · Founded 2016 · $101.0M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$101.0M
Last Round
$101.0M Series BJan 2021
Rounds
2

About

Bluefin Biomedicine is a privately held, clinical-stage biotechnology company advancing first-in-class antibody medicines anchored in human biology. Its integrated discovery platform combines proteomics-powered antigen identification with next-generation antibody engineering to resolve target expression within complex human tissues. This human tissue-anchored approach reveals previously inaccessible biology across immune pathways and tumor-intrinsic or tumor-associated mechanisms. Guided by these insights, Bluefin advances a focused portfolio of differentiated biologics designed to address serious inflammatory and oncologic diseases where current therapies fall short.

Summary

Bluefin Biomedicine is a Biotech company based in Beverly, United States, founded in 2016. It has raised $101.0M in total across 2 rounds, most recently a $101.0M Series B round in Jan 2021. Investors include Deerfield Management.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2021
$101.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bluefin Biomedicine on Indexed.vc
<a href="https://indexed.vc/companies/bluefin-biomedicine"><img src="https://indexed.vc/api/badge/company/bluefin-biomedicine" alt="Bluefin Biomedicine on Indexed.vc" width="260" height="76" /></a>